Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Fintel reports that on January 24, 2025, Oppenheimer downgraded their outlook for Exelixis (NasdaqGS:EXEL) from Outperform to ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

Scientists from the University of Colorado Anschutz Medical Campus noticed a curious pattern: midazolam might be connected to ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...

British authorities arrested two drug traffickers belonging to a larger organized crime group, thanks largely to intelligence gathered from a photo of a dog belonging to one of the suspects, a small ...